Fund manager · LIC

Dhaval Sangoi

Assistant Fund Manager & Equity Research Analyst at LIC. Runs 1 scheme worth ₹99.4 Cr.

Fund house
LICThey run their schemes at LIC.
AUM they run
₹99.4 CrThe AUM of the schemes they run, as main or co-manager, at the latest month's end, as AMFI reports it. A scheme two people run counts for both.
Schemes
1 now · 0 beforeSchemes they run now, as main or co-manager, and ones they ran before, since Aug 2026.
Experience
12 yearsOverall 12+ years of experience

What Dhaval Sangoi's schemes hold^{(Aug 2026 – Sept 2026)}

What Dhaval Sangoi's schemes hold in Sept 2026. Tick up to 2 to plot them.
Plot	25 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	9.5
	Divi s Laboratories Limited	9
	Neuland Laboratories Limited	6.1
	Torrent Pharmaceuticals Limited	6
	Apollo Hospitals Enterprise Limited	5.7
	Aurobindo Pharma	5.2
	Navin Flourine International Ltd	5
	Cadila Healthcare	4.9
	Aster DM Healthcare Limited	4.6
	Fortis Healthcare Limited	3.7
	Metropolis Healthcare Limited	3.3
	Gland Pharma Limited	3.2
	Mankind Pharma Limited	3.1
	Nephrocare Health Services Ltd	3
	Max Healthcare Institute Limited	3
	Cohance Lifesciences Limited	2.9
	Glenmark Pharmaceuticals	2.6
	Global Health Limited	2.6
	Dr Agarwal s Health Care Limited	2.4
	Biocon	2.4
	IPCA Laboratories Limited	2.3
	Onesource Speciality Pharma Ltd	2.3
	Piramal Pharma Limited	1.4
	Syngene International Limited	1.4
	Artemis Medicare Services Limited	1.3

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company across the schemes Dhaval Sangoi runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹0 Cr	₹0 Cr
Oct 2025	₹0 Cr	₹0 Cr
Nov 2025	₹0 Cr	₹0 Cr
Dec 2025	₹0 Cr	₹0 Cr
Jan 2026	₹0 Cr	₹0 Cr
Feb 2026	₹0 Cr	₹0 Cr
Mar 2026	₹0 Cr	₹0 Cr
Apr 2026	₹0 Cr	₹0 Cr
May 2026	₹0 Cr	₹0 Cr
Jun 2026	₹0 Cr	₹0 Cr
Jul 2026	₹0 Cr	₹0 Cr
Aug 2026	₹10.4 Cr	₹9.6 Cr
Sept 2026	₹9.5 Cr	₹9 Cr

Fig. 1.Market value of each ticked company across the schemes Dhaval Sangoi runs, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of AUM
Large Cap	4	30.45

Mid Cap	9	31.98

Small Cap	12	35.10

Cash & others		2.47

Sectors

Companies

Fig. 2.What the schemes this manager runs hold, all together, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

What Dhaval Sangoi bought and sold^{(Aug 2026 – Sept 2026)}

What Dhaval Sangoi bought and sold. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.